BlackRock Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

BlackRock Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$25K	Hold	4,500	–	–	﹤0.01%	3413
2016 Q3	$23K	Hold	4,500	–	–	﹤0.01%	3418
2016 Q2	$20K	Hold	4,500	–	–	﹤0.01%	3443
2016 Q1	$20K	Hold	4,500	–	–	﹤0.01%	3427
2015 Q4	$24K	Hold	4,500	–	–	﹤0.01%	3442
2015 Q3	$26K	Sell	4,500 -1,463	-25%	-$9.12K	﹤0.01%	3447
2015 Q2	$43K	Sell	5,963 -158	-3%	-$1.1K	﹤0.01%	3347
2015 Q1	$41K	Hold	6,121	–	–	﹤0.01%	3295
2014 Q4	$37K	Hold	6,121	–	–	﹤0.01%	3344
2014 Q3	$30K	Hold	6,121	–	–	﹤0.01%	3390
2014 Q2	$28K	Hold	6,121	–	–	﹤0.01%	3363
2014 Q1	$28K	Buy	6,121 +1,916	+46%	+$9.11K	﹤0.01%	3348
2013 Q4	$21K	Sell	4,205 -49,486	-92%	-$242K	﹤0.01%	3381
2013 Q3	$243K	Sell	53,691 -43,550	-45%	-$217K	﹤0.01%	2420
2013 Q2	$497K	Buy	+97,241	New	+$484K	﹤0.01%	1834

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BlackRock Advisors's CPIX Position: Q4 2016 in Review

BlackRock Advisors held its Cumberland Pharmaceuticals (CPIX) position steady in Q4 2016 at 4,500 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

BlackRock Advisors first reported a position in CPIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $497K in Q2 2013. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.

BlackRock Advisors held 4,500 shares of Cumberland Pharmaceuticals worth $25K as of Q4 2016.
BlackRock Advisors left its Cumberland Pharmaceuticals share count unchanged in Q4 2016.
Cumberland Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3413 holding.
BlackRock Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Cumberland Pharmaceuticals position peaked at $497K in Q2 2013.
41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.